Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management

被引：4

作者：

Citrome, Leslie ^{[1
]}

Meyer, Jonathan M. ^{[2
]}

机构：

[1] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY 10595 USA

[2] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA USA

来源：

JOURNAL OF CLINICAL PSYCHIATRY | 2023年 / 84卷 / 04期

关键词：

RECEPTORS; XANOMELINE;

D O I：

10.4088/JCP.sunscz3001sho

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：80 / 81

页数：2

共 22 条

[1]

[Anonymous], A Trial of 10 and 30 Mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

[2] Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges [J].

Berry, Mark D. ;

Gainetdinov, Raul R. ;

Hoener, Marius C. ;

Shahid, Mohammed .

PHARMACOLOGY & THERAPEUTICS, 2017, 180 :161-180

[3] Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia [J].

Brannan, Stephen K. ;

Sawchak, Sharon ;

Miller, Andrew C. ;

Lieberman, Jeffrey A. ;

Paul, Steven M. ;

Breier, Alan .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08) :717-726

[4] Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results [J].

Breier, Alan ;

Brannan, Stephen K. ;

Paul, Steven M. ;

Miller, Andrew C. .

PSYCHOPHARMACOLOGY, 2023, 240 (05) :1191-1198

[5] Vive la revolution! a paradigm shift in the pharmacological treatment of schizophrenia [J].

Citrome, Leslie .

CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (03) :473-474

[6] Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors [J].

Correll, Christoph U. ;

Solmi, Marco ;

Croatto, Giovanni ;

Schneider, Lynne Kolton ;

Rohani-Montez, S. Christy ;

Fairley, Leanne ;

Smith, Nathalie ;

Bitter, Istvan ;

Gorwood, Philip ;

Taipale, Heidi ;

Tiihonen, Jari .

WORLD PSYCHIATRY, 2022, 21 (02) :248-271

[7] Emerging Treatments in Schizophrenia [J].

Correll, Christoph U. ;

Abi-Dargham, Anissa ;

Howes, Oliver .

JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (01)

[8] Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study [J].

Correll, Christoph U. ;

Koblan, Kenneth S. ;

Hopkins, Seth C. ;

Li, Yan ;

Dworak, Heather ;

Goldman, Robert ;

Loebel, Antony .

NPJ SCHIZOPHRENIA, 2021, 7 (01)

[9]

Correll CU, 2022, 35 ECNP C OCT 15 18

[10] Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care [J].

De Hert, Marc ;

Correll, Christoph U. ;

Bobes, Julio ;

Cetkovich-Bakmas, Marcelo ;

Cohen, Dan ;

Asai, Itsuo ;

Detraux, Johan ;

Gautam, Shiv ;

Moeller, Hans-Jurgen ;

Ndetei, David M. ;

Newcomer, John W. ;

Uwakwe, Richard ;

Leucht, Stefan .

WORLD PSYCHIATRY, 2011, 10 (01) :52-77

← 1 2 3 →